Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galena Biopharma Inc (NASDAQ:GALE)

0.315
Delayed Data
As of Dec 15
 -0.005 / -1.56%
Today’s Change
0.26
Today|||52-Week Range
3.60
-83.76%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.4M

Company Description

Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.

Contact Information

Galena Biopharma, Inc.
2000 Crow Canyon Place
San Ramon California 94583
P:(925) 498-7700
Investor Relations:
(503) 405-8258

Employees

Shareholders

Individual stakeholders6.03%
Mutual fund holders2.72%
Other institutional17.68%

Top Executives

Stephen F. GhiglieriCEO, CFO & Principal Accounting Officer
Bijan NejadnikChief Medical Officer & Executive Vice President
Joseph LasagaVP-Business Development & Alliance Management
John T. BurnsVice President-Finance & Controller
Remy BernardaSVP-Investor Relations & Corporate Communications